Advancing precision medicine through a growing lab

The ecosystem for precision medicine is excellent in Trondheim, with projects PRESORT, DrugLogics, MATRIX, COLOGIC, ERA PerMed project OncoLogics, COSENSE, and IMPRESS including new young researchers. 

A flow chart of the Flobak Lab and who is doing what, including supporters and funders.

The Flobak lab is growing, and there are now a total of eight persons working together towards computational functional precision medicine. 

New names and roles

Phd fellows Cristoffer Sakshaug and Ingrid A. Bergstrøm work on patient inclusion in the PRESORT and MATRIX projects together with support from St Olav’s hospital. Phd fellow Henri Colyn Bwanika is roboticizing and miniatyrizing patient-derived cell culturing in 3D setups to test various drugs on the patient’s own cells in the COLOGIC project, in close collaboration with SINTEF. Phd fellow Rianne van Drimmelen is studying omics data from patient-derived tumoroids prior and after drug exposure. Postdoc Christa Ringers uses high content imaging for the identification of new cell phenotypes. Phd fellow Viviam Bermúdez and researcher Eirini Tsirvouli in OncoLogics and DrugLogics projects convert omics data for patients to patient-centered models, digital twins, to prioritise which drugs to test on each patient’s cells. MDs Ingrid and Cristoffer seek ways to enable clinical decision support in the COSENSE clinical trial. 

 

Important partners and supporters

The Flobak lab is grateful to receive support and funding from NTNU, Helse Midt-Norge, ERA PerMed, The Norwegian Cancer Society and The Research Council of Norway to advance the precision medicine frontier one - or maybe two - steps further. 


 

Published May 22, 2024 4:57 PM - Last modified May 28, 2024 11:53 AM